| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |